Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs Nouri

HealthRX
Graded #8

Higher grade

vs+31.299999999999997
Nouri
Graded #454

Lower grade

The verdict

HealthRX takes it — 86.1/100 to 54.8/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +40
85
45
Dose & formulationHealthRX +50
90
40
Clinical oversightHealthRX +23
87
64
Labs & monitoringHealthRX +29
82
53
FulfillmentNouri +1
86
87
Contract termsHealthRX +30
85
55
HealthRX · left barNouri · right bar

The numbers

MetricHealthRXNouri
WeighScore86.1/10054.8/100
GradeBC
Scorecard rank#8#454
Semaglutide$189/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageNot publicly listedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
HealthRX

Graded #8 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
Nouri

Graded #454 · C

Strengths

  • Named clinical MSO partner (Wasef Health, PC; Michael Wasef, MD) with public contact email
  • Named 503A compounding pharmacy partner (Jungle Jim's Pharmacy, Fairfield OH) with full address
  • Available in all 50 states per the FAQ
  • Flat per-dose pricing within each tier — no dose-escalation surcharge
  • Nutrition and movement coaching included in the medication price

Where it loses points

  • Compounded medications only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Operating entity name not disclosed in the Terms of Service
  • Terms 'where we operate' language is slightly weaker than the FAQ's all-50-states claim
  • Video visit required in some states, but those states aren't listed
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard